The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
October 30th 2024
A decade after bariatric surgery, most teens maintained weight loss and reduced obesity-related conditions such as type 2 diabetes and hypertension.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Drug Proven to Provide Diabetic Nephropathy Relief
June 6th 2015Oxidative stress plays an important role in the ability for dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, to effectively ease diabetic nephropathy, according to lead author Takashi Hatanaka of Nagoya University. The study will be presented in a poster session on June 6 at the American Diabetes Association 75th Scientific Sessions in Boston, MA.
The Diabetes Pandemic Requires Global Policy Solutions
The global pandemic of diabetes poses a huge public health challenge to every nation. In 2014 more than 380 million people around the world were living with diabetes-8.3% of the adult population. That number is expected to increase to 592 million by 2035.
Increased Risk of Fractures Associated with Subclinical Thyroid Dysfunction
Overt hyperthyroidism is a known risk factor for osteoporosis and fractures. More subtle alterations in thyroid function, such as those that occur in subclinical thyroid dysfunction, may also be associated with increased fracture risk and bone loss, but until recently no clinical trials have adequately explored that issue.
Overuse of Antibiotics in Primary Health Care: Patient Education Crucial, Too
A recent Chinese study of antibiotic use in primary care settings found that up to 93% of respiratory tract infections (RTIs) were treated with antibiotics, with more than 60% reported as inappropriate.
Yet Another Coffee Study Says It's OK to Drink Up
May 29th 2015Danish researchers conducted a meta-analysis that looked at possible associations between coffee intake and obesity, metabolic syndrome, and type 2 diabetes. They reported finding only a low risk of these conditions in coffee drinkers, but no genetic variance to explain the relationships.
Referral to an Endocrinologist: Which Diabetes Patients Benefit the Most?
May 29th 2015With the global boom in type 2 diabetes mellitus, many patients have greatest access to and are well-cared for by their primary care practitioners (PCPs). For those with basic, predictable, garden-variety diabetes, PCPs are perfectly capable of helping them. It's unclear when referral to a specialist for consultation or chronic management is most sensible.
Understanding the Obese Patient
May 26th 2015Obesity rates have climbed nearly 50 percent since 1997, with as much as 30 percent of the population classified as obese. There is strong belief within the health care industry that obesity should be treated as a primary medical condition, with physicians playing a major role. Evidence suggests that patients are more likely to lose weight when they are advised by their primary care physicians to do so.
GLP-1 Receptor Agonists and Thyroid Cancer: Differentiating Cancer Type
May 22nd 2015GLP-1 receptor antagonists have been associated with thyroid cancer in rodents, and in fact carry a boxed warning about the potential for cancer in humans. This leads many clinicians to ask if they should be concerned about using these drugs in patients who have or develop specific types of thyroid cancer
Diabetes Drug Addresses Inflammation in HIV Patients
May 22nd 2015Sitagliptin appears to have beneficial systemic and adipose anti-inflammatory effects in combination antiretroviral therapy-treated HIV-positive adults with impaired glucose tolerance. The drug may prevent cardiovascular problems by reducing inflammation linked to heart disease and stroke in this patient population.
Antipsychotics Safe for Pregnant Women
May 21st 2015The results of the largest study of its kind to date indicate that new antipsychotic medications-including quetiapine, olanzapine, and risperidone-do not appear to put women at additional risk of developing gestational diabetes, hypertensive disorders, or major blood clots that obstruct circulation, all conditions that often develop during pregnancy or with the use of older antipsychotic medications.
Working Through Safety Concerns and the Future of Computer Assisted Propofol Sedation
While there have been some concerns raised about computer assisted propofol sedation studies have shown it to be a safe and effective method when conducted by properly trained healthcare professionals. Work is also being done to ensure better results in the future.
Measuring Patient Experience With Computer Assisted Propofol Sedation
According to research done on computer assisted propofol sedation patients see a faster recovery time by approximately 6 minutes on average. This can help not only the patients to leave the recovery area faster, but can also put less of a burden on the staff and location of their endoscopic procedure.
What is Computer-Assisted Propofol Sedation?
When undergoing endoscopic procedures it is important that patients receive the proper pain medication. A recent study looked at whether a computer can assist in the process to keep the patients comfortable allow them to continue on their day after the procedure.
More than 13,000 physicians and cardiovascular team members attended the ACC 2015 meeting in San Diego on March 14-16, 2015. In this issue of Cardiology Review, we focus on 6 important studies presented at ACC 2015: LEGACY, OSLER, PEGASUS, EMBRACE-STEMI, MATRIX, and CoreValve.